Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates.
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
11
12
2020
Statut:
ppublish
Résumé
Novel therapeutic and preventive strategies are needed to contain the HIV-1 epidemic. Broadly neutralizing human antibodies (bNAbs) with exceptional activity against HIV-1 are currently being tested in HIV-1 prevention trials. The selection of anti-HIV-1 bNAbs for clinical development was primarily guided by their
Identifiants
pubmed: 33298542
pii: JVI.01909-20
doi: 10.1128/JVI.01909-20
pmc: PMC8092834
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : UM1 AI100663
Pays : United States
Informations de copyright
Copyright © 2020 Lorenzi et al.
Références
Cell. 2020 Feb 6;180(3):471-489.e22
pubmed: 32004464
Sci Transl Med. 2017 Jan 18;9(373):
pubmed: 28100831
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7908-E7916
pubmed: 27872306
J Virol. 2014 Nov;88(21):12669-82
pubmed: 25142607
J Virol. 2015 Oct 14;90(1):76-91
pubmed: 26468542
PLoS One. 2019 Aug 8;14(8):e0219142
pubmed: 31393868
Sci Transl Med. 2015 Dec 23;7(319):319ra206
pubmed: 26702094
Lancet HIV. 2019 May;6(5):e297-e306
pubmed: 31000477
J Virol. 2005 Aug;79(16):10108-25
pubmed: 16051804
J Virol. 2010 Oct;84(20):10510-21
pubmed: 20686044
Curr Opin HIV AIDS. 2019 May;14(3):153-160
pubmed: 30882484
Virology. 2005 Sep 1;339(2):226-38
pubmed: 16005039
J Exp Med. 2018 Sep 3;215(9):2311-2324
pubmed: 30072495
J Virol. 2014 Dec;88(23):13910-7
pubmed: 25231299
AIDS. 2009 Aug 24;23(13):1659-67
pubmed: 19581791
J Virol. 2015 Mar;89(5):2659-71
pubmed: 25520506
Nucleic Acids Res. 2015 Jul 1;43(W1):W213-9
pubmed: 26044712
Nature. 2015 Jun 25;522(7557):487-91
pubmed: 25855300
Nature. 2016 Jul 28;535(7613):556-60
pubmed: 27338952
J Virol. 2019 Mar 5;93(6):
pubmed: 30567994
J Virol. 2018 Feb 12;92(5):
pubmed: 29237833
Science. 2009 Oct 9;326(5950):285-9
pubmed: 19729618
J Virol. 2008 Jun;82(12):5807-14
pubmed: 18385254
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17624-9
pubmed: 25422458
Immunity. 2018 May 15;48(5):872-895
pubmed: 29768175
J Virol Methods. 2007 Jul;143(1):104-11
pubmed: 17416428
N Engl J Med. 2016 Nov 24;375(21):2037-2050
pubmed: 27959728
Science. 2011 Sep 16;333(6049):1633-7
pubmed: 21764753
PLoS One. 2011;6(12):e28632
pubmed: 22174851
PLoS Med. 2017 Nov 14;14(11):e1002435
pubmed: 29136037
Virology. 2012 May 25;427(1):25-33
pubmed: 22369748
PLoS Comput Biol. 2017 Oct 24;13(10):e1005789
pubmed: 29065122
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3268-77
pubmed: 23115339
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10598-603
pubmed: 23754383
N Engl J Med. 2010 Feb 4;362(5):427-39
pubmed: 20089951
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
Nature. 2018 Sep;561(7724):479-484
pubmed: 30258136
Nat Med. 2018 Nov;24(11):1701-1707
pubmed: 30258217
J Virol. 2017 Sep 12;91(19):
pubmed: 28747500
J Virol Methods. 2015 Mar;214:46-53
pubmed: 25681527
PLoS Pathog. 2013;9(7):e1003477
pubmed: 23853594
J Virol. 2010 May;84(9):4311-20
pubmed: 20164234
Nat Med. 2017 Feb;23(2):185-191
pubmed: 28092665
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Science. 2010 Aug 13;329(5993):856-61
pubmed: 20616233
Bioinformatics. 2010 Aug 1;26(15):1899-900
pubmed: 20427515
PLoS Pathog. 2018 Mar 5;14(3):e1006860
pubmed: 29505593
Curr Protoc Immunol. 2005 Jan;Chapter 12:Unit 12.11
pubmed: 18432938